BR (bendamustine plus rituximab) versus R-CHOP for patients with indolent B-cell lymphomas: a systematic review and Meta-analysis

Ou, WX; Jiang, TT; Tang, XQ

Tang, XQ (通讯作者)，Chongqing Med Univ, Dept Hematopathol, Affiliated Hosp 1, 1 Youyi Rd, Chongqing, Peoples R China.

JOURNAL OF CHEMOTHERAPY, 2023; 35 (1): 1

Abstract

Bendamustine plus rituximab (BR) and rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) have been shown to be effective i......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索